It is suggested that HIF-1α and HIF-2α are likely to play different roles at different stages of tumour formation and progression and that these roles might potentially be modulated by the spectrum of mutations present in each individual ccRCC [25]. This evidence concerns the gene EPAS1 and neoplasm.